首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 點滴療法與靜脈通道:全球市場
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

點滴療法與靜脈通道:全球市場

Intravenous (IV) Therapy and Vein Access: Global Markets

出版商 BCC Research
出版日期 2010年08月 商品編碼 128360
內容資訊 英文 151 Pages
價格
US $ 4850 PDF by E-mail ( Single User License)
US $ 5950 PDF by E-mail (Business Unit License)
US $ 8500 PDF by E-mail (Enterprise License)


點滴療法與靜脈通道:全球市場 是由出版商BCC Research在2010年08月所出版的。 這份英文市場調查報告書包含151 Pages 價格從美金4850起跳。

簡介

2009年,全球的點滴(IV)療法與靜脈通道市場價值幾乎逼近88億美元,預計將於2014年則達到112億美元。

此報告書針對點滴療法與靜脈通道市場之概要與業界背景情報,提供各種類市場動向、技術動向與競合分析、以及企業檔案等,以下列概略為您呈現。

第1章 簡介

第2章 重點摘要

第3章 業界概要

  • 輸液療法之歷史發展
  • 注入療法的背景
  • 循環系統之機能
  • 一般的點滴
  • 注入pump
  • 注入率
  • 自由流量
  • 開始時間
  • 一般的特性與安全對策
  • 風險管理
  • 注入pump之性能
  • 閉塞
  • 注射設備之特徵、規制與配置
  • 安全問題
  • 考慮到患者的舒適性
  • 新材料與簡單的設計
  • 保健償還問題
  • 革新的治療方法
  • 較少tube的pump
  • 注射壓力
  • 在醫院使用
  • 於住家打點滴所帶來的影響
  • 醫藥品專用設備
  • 點滴療法之教育
  • 自宅通訊注射設備
  • 使用者促進了技術革新
  • 注射pump問題與回收
  • 業界統合問題
  • 學名藥之加入
  • 外科與注射療法
  • 看護施設與注射療法
  • 販賣點滴設備
  • 攜帶式注射pump
    • 製品
    • 市場與競合資料
  • 中心静脈管道設備
    • 風險
    • 製品
    • 市場與競合資料
  • 糖尿病用胰島素注射pump
    • 製品
    • 市場與競合資料
  • 外部注射pump與tube
    • 製品
    • 市場與競合資料
  • 埋入式注射pump
  • 大型針筒注射pump
  • 末梢靜脈管道設備
  • 針筒注射pump
  • 其他

第4章 市場規模與擴大

  • 近年來的發展

第5章 技術分析

第6章 市場分析

第7章 競合分析

第8章 市場展望

第9章 企業檔案

附錄

目錄

Abstract

HIGHLIGHTS:

  • In 2009, the total global intravenous therapy and vein access market reached nearly $8.8 billion and is forecast to reach $11.2 billion in 2014, a compound annual growth rate (CAGR) of 5%.
  • Insulin-infusion pumps are expected to show the greatest demand over the forecast period. This segment was worth $1.1 billion in 2009 and is expected to increase at an 8.1% compound annual growth rate (CAGR) to reach $1.6 billion in 2014.
  • The central venous access devices and implantable pumps segment will experience a 5.7% compound annual growth rate (CAGR) over the forecast period. This market was valued at $975 million in 2009 and is expected to reach a value of nearly $1.3 billion in 2014.

STUDY GOALS AND OBJECTIVES

The objectives of the study are to present a comprehensive look at the intravenous (IV) therapy device and vein access market.

There are eight general categories of IV therapy:

  • Ambulatory infusion pumps
  • Central venous access devices
  • Diabetes insulin-infusion pump
  • Enteral feeding pump and tubes
  • Implantable pumps
  • Large-volume infusion pumps
  • Peripheral venous access devices
  • Syringe infusion pumps

REASONS FOR STUDY

This BCC study is presented to increase the awareness of IV therapy devices and vein access. The study analyzes the IV therapy market from different standpoints and addresses issues and trends affecting IV therapy administration. IV therapy and vein access device manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of innovative devices. Because of the evolving nature of this important area of medicine, executives of IV therapy devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of IV therapy.

SCOPE OF STUDY

This report is a comprehensive business tool designed to provide an in-depth look at the market for IV therapy and vein access. The geographic scope of the report is the global. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.

Categories discussed in the report include:

  • Ambulatory infusion pumps
  • Central venous access devices
  • Diabetes insulin-infusion pump
  • Enteral feeding pump and tubes
  • Implantable pumps
  • Large-volume infusion pumps
  • Peripheral venous access devices
  • Syringe infusion pumps.

All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2009 to 2014, and assessing the competitors and competitor market shares.

METHODOLOGY AND INFORMATIO SOURCES

The information and analysis presented in this BCC report are based on extensive firsthand interviews with primary executives, product managers, and clinical specialists in the intravenous infusion and vein access arena. Background information was obtained from various government agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the administration of intravenous therapy and vein access.

Key information from published literature was used to conduct interviews with over 22 industry participants to validate and obtain expert opinions on current and future trends in the IV therapy and vein access industry. Interviews were the primary basis for development of market size. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulating market projections.

All market data pertain to the global market at the manufacturer's level. Data are expressed in current U.S. dollars. The base year was 2009. Historical data are provided for 2008 and forecast data are provided for 2014. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2009 base year.

ANALYST CREDENTIALS

Mary Anne Crandall is an expert industry analyst specializing in the pharmaceutical industry for the last 18 years. She has completed several in-depth studies on various medical topics requiring both medical expertise and excellent knowledge of the pharmaceutical industry. Ms. Crandall has extensive knowledge in the medical field, has a MS in psychology, and is currently working on a PhD.

Table of Contents

Intravenous (IV) Therapy and Vein Access: Global Markets

Chapter- 1: INTRODUCTION -- Complimentary

  • CHAPTER ONE: INTRODUCTION
  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR STUDY
  • SCOPE OF STUDY
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • RELATED BCC REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter-2: EXECUTIVE SUMMARY

  • CHAPTER TWO: EXECUTIVE SUMMARY
  • EXECUTIVE SUMMARY (CONTINUED) (CONTINUED)
  • SUMMARY TABLE GLOBAL MARKET FORECAST FOR IV THERAPY
  • DEVICE AND VEIN ACCESS MARKETS, THROUGH ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL MARKET FORECAST IV THERAPY DEVICE AND VEIN ACCESS MARKETS, 2009 AND 2014 ($ MILLIONS)

Chapter-3: INDUSTRY OVERVIEW

  • CHAPTER THREE: INDUSTRY OVERVIEW
  • HISTORICAL DEVELOPMENT OF TRANSFUSION THERAPY
  • BACKGROUND TO INFUSION THERAPY
  • FUNCTIONS OF THE CIRCULATORY SYSTEM
  • CIRCULATORY SYSTEM
  • GENERAL PRINCIPLES OF IV THERAPY
  • TYPES OF IV ADMINISTRATION
  • Continuous Intravenous Drip
  • Bolus
  • Intravenous Push
  • Titration
  • INFUSION PUMPS
  • INFUSION RATE
  • INFUSION RATE (CONTINUED)
  • FREE FLOW
  • START-UP TIME
  • GENERAL FEATURES AND SAFEGUARDS
  • RISK MANAGEMENT
  • SOPHISTICATION OF INFUSION PUMPS
  • OCCLUSIONS
  • OCCLUSIONS (CONTINUED)
  • CHARACTERISTICS, LIMITATIONS, AND CONFIGURATION OF INFUSION DEVICES
  • SAFETY ISSUES
  • SAFETY ISSUES (CONTINUED)
  • SAFETY ISSUES (CONTINUED)
  • PATIENT COMFORT
  • PATIENT COMFORT (CONTINUED)
  • NEW MATERIALS AND SIMPLER DESIGNS
  • INSURANCE REIMBURSEMENT ISSUES
  • INSURANCE REIMBURSEMENT ISSUES (CONTINUED)
  • 2010 CODING AND REIMBURSEMENT GUIDE
  • INNOVATIVE TREATMENT OPTIONS
  • TUBELESS PUMPS
  • INFUSION DELIVERY PRESSURE
  • HOSPITAL INFUSION
  • IMPACT OF HOME INFUSION THERAPY
    • TABLE 1. TYPES OF HOME CARE/ALTERNATIVE SITES
  • KEY FACTORS FUELING THE GROWTH IN HOME CARE
  • Demographics
    • TABLE 2. U.S. OLDER POPULATION BY AGE GROUP
    • TABLE 2. (CONTINUED)
    • TABLE 3. GLOBAL POPULATION BY SELECTED GEOGRAPHICAL REGION, 2008-5050 ($ MILLIONS)
    • FIGURE 1. GLOBAL POPULATION BY SELECTED GEOGRAPHICAL REGION, 2008 - 2050 (MILLIONS)
  • Technology
  • Managed Care
  • HOME/ALTERNATE SITE INFUSION PROVIDERS
  • Regulation
  • Provider Trends
  • PHARMACEUTICAL SPECIALTY DELIVERY
  • GROWTH POTENTIAL
  • MEDICARE PART D
  • IV THERAPY EDUCATION
  • HOME TELEINFUSION
  • HOME TELEINFUSION (CONTINUED)
  • HOME TELEINFUSION (CONTINUED)
  • HOME TELEINFUSION (CONTINUED)
  • USER-DRIVEN INNOVATIONS
  • INFUSION PUMP PROBLEMS AND RECALLS
  • INFUSION PUMP PROBLEMS AND RECALLS (CONTINUED)
  • INFUSION PUMP PROBLEMS AND RECALLS (CONTINUED)
  • VERTICAL INTEGRATION ISSUES
  • GENERIC PARTICIPATION
  • SURGERY AND INFUSION THERAPY
    • TABLE 4. INPATIENT PROCEDURES, 2007 (THOUSANDS)
    • TABLE 4. (CONTINUED)
    • FIGURE 2. INPATIENT PROCEDURES, 2007 (THOUSANDS)
  • SKILLED NURSING FACILITIES AND INFUSION THERAPY
    • TABLE 5. SKILLED NURSING FACILITIES AND BEDS, 2005 AND 2007
  • DEMOGRAPHICS
    • TABLE 6. U.S. DEMOGRAPHICS BY SEX AND AGE, 2008-2015(MILLIONS)
    • TABLE 6. (CONTINUED)
    • FIGURE 3. U.S. DEMOGRAPHICS BY SEX AND AGE, 2008-2015 (MILLIONS)
  • DISTRIBUTION OF INTRAVENOUS THERAPY EQUIPMENT
  • AMBULATORY INFUSION PUMPS
  • SELECT PRODUCTS
  • Ipump Infusion Pump
  • CADD Infusion Pumps
  • WalkMed IC Infusion Pump
  • GemStar Infusion Pump
  • Alaris Gemini PC1 Infusion Pump
  • 2000 Plus Infusion Pump
  • Paragon and Vivus 4000 Infusion Pumps
  • VIP and Sidekick Infusion Pump
  • ambIT Patient-Controlled Analgesia (PCA) Infusion Pump
  • Eureka-IPTM Infusion Pump
  • Delphi IVantage Infusion Pump
    • TABLE 7. SELECTED AMBULATORY INFUSION PUMPS AND MANUFACTURERS
    • TABLE 7. (CONTINUED)
  • MARKET AND COMPETITIVE DATA
    • TABLE 8. GLOBAL MARKET FORCAST FOR AMBULATORY INFUSION PUMPS, THROUGH 2014 ($ MILLIONS)
    • FIGURE 4. GLOBAL MARKET FORECAST FOR AMBULATORY INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS)
    • TABLE 9. MANUFACTURERS' MARKET SHARE OF AMBULATORY INFUSION PUMPS, 2009 (%)
    • FIGURE 5. MANUFACTURERS' MARKET SHARE OF AMBULATORY INFUSION PUMPS, 2009 (%)
  • CENTRAL VENOUS ACCESS DEVICES
  • CENTRAL VENOUS ACCESS DEVICES (CONTINUED)
  • CENTRAL VENOUS ACCESS DEVICES (CONTINUED)
  • RISKS
  • PRODUCTS
  • Arrow Multi-Lumen Access Catheter
  • Hickman, Leonard, Broviac, and Groshong Catheters
  • Cook Catheter
  • Circle C Chronic and Acute Hemodialysis Catheters
  • NeoStar
  • LifePort and Infuse-A-Port System
  • Dignity, HemoCath LT
  • Vantex Catheter
    • TABLE 10. SELECTED CENTRAL VENOUS ACCESS DEVICES AND MANUFACTURERS
  • MARKET AND COMPETITIVE DATA
    • TABLE 11. GLOBAL MARKET FORECAST FOR CENTRALVENOUS ACCESSES, THROUGH 2014 ($ MILLIONS)
    • FIGURE 6. GLOBAL MARKET FORECAST FOR CENTRAL VENOUS ACCESSES, 2009 AND 2014 ($ MILLIONS)
    • TABLE 12. MANUFACTURERS' MARKET SHARE OF CENTRAL VENOUS ACCESS, 2009 (%)
    • FIGURE 7. MANUFACTURERS' MARKET SHARE OF CENTRAL VENOUS ACCESS, 2009 (%)
  • DIABETES INSULIN-INFUSION PUMPS
  • DIABETES INSULIN-INFUSION PUMPS (CONTINUED)
  • DIABETES INSULIN-INFUSION PUMPS (CONTINUED)
  • PRODUCTS
  • MiniMed Paradigm
  • MIP 2001 Promedos ID3
  • Infusaid Model 1000
  • Infusaid Model 1000 (Continued)
  • ACCU-CHEK Spirit Insulin Pump
  • Animas Insulin Pumps
  • OmniPod Insulin Management System
  • DANA Diabecare II and Diabecare IISG
  • ADI Insulin Pump
  • Amigo Insulin Pump
    • TABLE 13. SELECTED INSULIN-INFUSION PUMPS AND MANUFACTURERS
  • MARKET AND COMPETITIVE DATA
    • TABLE 14. GLOBAL MARKET FORECAST FOR DIABETES INSULIN INFUSION PUMPS, THROUGH 2014 ($ MILLIONS)
    • FIGURE 8. GLOBAL MARKET FORECAST FOR DIABETES INSULIN-INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS)
    • TABLE 15. MANUFACTURERS' MARKET SHARE OF DIABETES INSULIN INFUSION PUMPS, 2009 (%)
    • FIGURE 9. MANUFACTURERS' MARKET SHARE OF DIABETES INSULIN-INFUSION PUMPS, 2009 (%)
  • ENTERAL FEEDING PUMPS AND TUBES
  • PRODUCTS
  • Flexiflo, Quantum, and Patrol Enteral Pumps
  • Kangaroo Enteral Pumps
  • Noa III
  • Zevex Enteral Pumps
  • ALASKA, Applix Smart, Miniflo, Pilot
  • Q Core EF34
  • Compat Enteral Pump
    • TABLE 16. SELECTED ENTERAL FEEDING PUMPS AND MANUFACTURERS
  • MARKET AND COMPETITIVE DATA
    • TABLE 17. GLOBAL MARKET FORECAST FOR ENTERAL FEEDING PUMPS AND TUBES, THROUGH 2014 ($ MILLIONS)
    • FIGURE 10. GLOBAL MARKET FORECAST FOR ENTERAL FEEDING PUMPS AND TUBES, 2009 AND 2014 ($ MILLIONS)
    • TABLE 19. MANUFACTURERS' MARKET SHARE OF ENTERAL FEEDING PUMPS AND TUBES, 2009 (%)
    • FIGURE 11. MANUFACTURERS' MARKET SHARE OF ENTERAL FEEDING PUMPS AND TUBES, 2009 (%)
  • IMPLANTABLE INFUSION PUMPS
  • ACCESS PORTS
  • PULSATIVE PUMPS
  • VAPOR-PRESSURE-POWERED PUMPS
  • PERISTALTIC PUMPS
  • Peristaltic Pumps (Continued)
  • PRODUCTS
  • SynchroMed Infusion System
  • MARKET AND COMPETITIVE DATA
    • TABLE 19. GLOBAL MARKET FORECAST FOR IMPLANTABLE INFUSION PUMPS, THROUGH 2014
    • FIGURE 12. GLOBAL MARKET FORECAST FOR IMPLANTABLE INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS)
    • TABLE 20. MANUFACTURERS' MARKET SHARE OF IMPLANTABLE INFUSION PUMPS, 2009 (%)
    • FIGURE 13. MANUFACTURERS' MARKET SHARE OF IMPLANTABLE INFUSION PUMPS, 2009 (%)
  • LARGE-VOLUME INFUSION PUMPS
  • PRODUCTS
  • COLLEAGUE Pump
  • FLO-GARD 6201 AND 6301
  • Hospira Plum A+/Plum A+3 Infusion Systems
  • Symbiq
  • Omni-Flow 4000 Plus
  • Horizon Nxt
  • Optima MS
  • MedSystem III
  • Z-800
  • Deltec 3000 and Deltec Micro 3100
    • TABLE 21. SELECTED LARGE-VOLUME PUMPS AND MANUFACTURERS
  • MARKET AND COMPETITIVE DATA
    • TABLE 22. GLOBAL MARKET FORECAST FOR LARGE-VOLUME INFUSION PUMPS, THROUGH 2014 ($ MILLIONS)
    • FIGURE 14. GLOBAL MARKET FORECAST FOR LARGE-VOLUME INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS)
    • TABLE 23. MANUFACTURERS' MARKET SHARE OF LARGE VOLUME INFUSION PUMPS, 2009
    • FIGURE 15. MANUFACTURERS' MARKET SHARE OF LARGE-VOLUME INFUSION PUMPS, 2009 (%)
  • PERIPHERAL VENOUS ACCESS DEVICES
  • PRODUCTS
  • Xcela and Vaxcel with PASV Valved Venous Access
  • V-Cath
  • Poly RadPICC, PowerPICC Solo, Power Groshong PICC, Poly Per-Q-Cath
  • Vygon Lifevac PICC and Nutriline Midline/Midclavicular Catheters
  • Argyle PICC
  • ProPICC CT
  • Morpheus CT PICC
  • BD First PICC Catheter and BD First Midcath Midline Catheter
    • TABLE 24. SELECTED PERIPHERAL VENOUS ACCESS DEVICES AND MANUFACTURERS
  • MARKET AND COMPETITIVE DATA
    • TABLE 25. GLOBAL MARKET FORECAST FOR PERIPHERAL VENOUS ACCESS DEVICES, THROUGH 2014 ($ MILLIONS)
    • FIGURE 16. GLOBAL MARKET FORECAST FOR THE PERIPHERAL VENOUS ACCESS DEVICES, 2009 AND 2014 ($ MILLIONS)
    • TABLE 26. MANUFACTURERS' MARKET SHARE OF PERIPHERAL VENOUS ACCESS DEVICES, 2009 (%)
      • FIGURE 17. MANUFACTURERS' MARKET SHARE OF PERIPHERAL VENOUS ACCESS DEVICES, 2009 (%)
    • SYRINGE INFUSION PUMPS
    • PRODUCTS
    • Alaris Syringe Line
    • MicroFuse Syringe Pumps
    • AS50A Infusion Pump
    • NIKI
    • LifeCare PCA
    • Injectomat, Master, and Pilot
    • Excelsior Syringe Pump
    • Graseby Syringe Drivers
    • OutBound Disposable Syringe Infuser
    • Medfusion Line
    • FREEDOM60 Syringe Infusion System
      • TABLE 27. SELECTED SYRINGE PUMPS AND MANUFACTURERS
    • MARKET AND COMPETITIVE DATA
      • TABLE 28. GLOBAL MARKET FORECAST FOR SYRINGE INFUSION PUMPS, THROUGH 2014 ($ MILLIONS)
      • FIGURE 18. GLOBAL MARKET FORECAST FOR SYRINGE INFUSION PUMPS, 2009 AND 2014 ($ MILLIONS)
      • TABLE 29. MANURACTURERS' MARKET SHARE OF SYRINGE INFUSION PUMPS, 2009 (%)
      • FIGURE 19. MANUFACTURERS' MARKET SHARE OF SYRINGE INFUSION PUMPS, 2009 (%)
    • OTHER
    • OTHER (CONTINUED)

    Chapter-4: TOTAL MARKET SIZE AND GROWTH

    • CHAPTER FOUR: TOTAL MARKET SIZE AND GROWTH
      • TABLE 30. GLOBAL MARKET FORECAST FOR IV THERAPY DEVICE AND VEIN ACCESS, TROUGH 2014 ($ MILLIONS)
      • FIGURE 20. GLOBAL MARKET FORECAST FOR I.V. THERAPY DEVICE AND VEIN ACCESS MARKETS, 2009 AND 2014 ($ MILLIONS)
      • FIGURE 21. MARKET SIZE OF GLOBAL I. V. THERAPY DEVICE AND VEIN ACCESS MARKETS, 2009 (%)
    • RECENT DEVELOPMENTS
    • NANOPUMP
    • DISPOSABLE CSII
    • PATCH CSII
    • LIGHTY
    • SOLO MICROPUMP
    • EKPUMP
    • PDD INNOVATIONS
    • FLUIDNET

    Chapter-5: TECHNOLOGY ANALYSIS

    • CHAPTER FIVE: TECHNOLOGY ANALYSIS
      • TABLE 31. U.S. PATENT INFORMATION BY DATE FOR INFUSION/INTRAVENOUS PUMPS AND RELATED DEVICES
      • TABLE 31. (CONTINUED)

    Chapter-6: MARKET ANALYSIS

    • CHAPTER SIX: MARKET ANALYSIS
    • MARKET ANALYSIS
    • MARKET ANALYSIS (CONTINUED)

    Chapter-7: COMPETITIVE ANALYSIS

    • CHAPTER SEVEN: COMPETITIVE ANALYSIS
      • TABLE 32. IV THERAPY DEVICE AND VEIN ACCESS MANUFACTURERS BY TYPE, 2009
      • TABLE 32. (CONTINUED)

    Chapter-8: MARKET OUTLOOK

    • CHAPTER EIGHT: MARKET OUTLOOK

    Chapter-9: COMPANY PROFILES

    • CHAPTER NINE: COMPANY PROFILES
    • JOHNSON & JOHNSON/ANIMAS CORPORATION
      • HISTORY
        • Revenue History
    • BAXTER INTERNATIONAL, INC.
      • HISTORY
        • Revenue History
    • B. BRAUN MELSUNGEN AG
      • HISTORY
        • Revenue History:
    • BECTON, DICKINSON AND COMPANY
      • HISTORY
        • Revenue History
    • CAREFUSION, INC.
      • HISTORY
        • Revenue History
    • COVIDIEN PLC
      • HISTORY
        • Revenue History:
    • FRESENIUS KABI, LTD.
      • HISTORY
        • Revenue History
    • HOSPIRA, INC.
      • HISTORY
        • Revenue History
    • I FLOW CORPORATION
      • HISTORY
        • Revenue History
    • INSULET CORPORATION
      • HISTORY
        • Revenue History
    • IRADIMED CORPORATION
      • HISTORY
        • Revenue History
    • MEDEX, INC.
      • HISTORY
        • Revenue History
    • MEDTRONIC, INC.
      • HISTORY
        • Revenue History
    • SMITHS MEDICAL
      • HISTORY
        • Revenue History
    • TELEFLEX, INC.
      • HISTORY
        • Revenue History:
    • ZEVEX, INC/MOOG
      • HISTORY
        • Revenue History

    APPENDIX

    • APPENDIX
      • TABLE 33. INFUSION DEVICE DEVELOPMENTS/MANUFACTURERS
      • TABLE 33. (CONTINUED)
      • TABLE 33. (CONTINUED)
      • TABLE 33. (CONTINUED)
      • TABLE 33. (CONTINUED)
      • TABLE 33. (CONTINUED)
Back to Top